Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14^ARF Tumor Suppressor

REFERENCES

• Afshari, C. A., Vojta, P. J., Annab, L. A., Futreal, P. A., Willard, T. B., and Barrett, J. C.. 1993. Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp. Cell Res. 209:231–237
   PubMedGoogle Scholar
• Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., and Barrett, J. C.. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742–13747
   PubMed Web of Science ®Google Scholar
• Atadja, P., Wong, H., Garkavstev, I., Veillette, C., and Riabowol, K.. 1995. Increased activity of p53 in senescing fibroblasts. Proc. Natl. Acad. Sci. USA 92:8348–8352
   PubMed Web of Science ®Google Scholar
• Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., and Voudsen, K. H.. 1998. p14ARF links the tumor suppressors RB and p53. Nature 395:124–125
   PubMed Web of Science ®Google Scholar
• Blattner, C., Sparks, A., and Lane, D.. 1999. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol. Cell. Biol. 19:3704–3713
   PubMed Web of Science ®Google Scholar
• Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E.. 1998. Extension of life span by introduction of telomerase into normal human cells. Science 279:349–352
   PubMed Web of Science ®Google Scholar
• Campisi, J.. 1997. Aging and cancer: the double-edged sword of replicative senescence. J. Am. Geriatrics Soc. 45:1–6
   PubMedGoogle Scholar
• Campisi, J.. 1996. Replicative senescence: an old lives tale? Cell 84:497–500
   PubMed Web of Science ®Google Scholar
• Campisi, J., Dimri, G. P., and Hara, E.. 1996. Control of replicative senescence Handbook of the biology of aging, 4th ed. Schneider, E., and Rowe, J. 121–149 Academic Press, New York, N.Y
   Google Scholar
• Chen, Q., Bartholomew, J. C., Campisi, J., Acosta, M., Reagen, J. D., and Ames, B.. 1998. Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G(1) arrest but not cell replication. Biochem. J. 332:43–50
   PubMed Web of Science ®Google Scholar
• DeGregori, J., Kowalik, T., and Nevins, J. R.. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S regulatory genes. Mol. Cell. Biol. 15:4215–4224
   PubMed Web of Science ®Google Scholar
• DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J. R.. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245–7250
   PubMed Web of Science ®Google Scholar
• DiLeonardo, A., Linke, S. P., Clarkin, K., and Wahl, G. M.. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540–2551
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., Campisi, J., and Cold Spring Harbor Press. 1994. Molecular and cell biology of replicative senescence. Mol. Gen. Cancer 59:67–73
   Google Scholar
• Dimri, G. P., Hara, E. E., and Campisi, J.. 1994. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J. Biol. Chem. 269:16180–16186
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O. M., Peacocke, M., and Campisi, J.. 1995. A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363–9367
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., Nakanishi, M., Desprez, P. Y., Smith, J. R., and Campisi, J.. 1996. Inhibition of E2F activity by the p21 inhibitor of cyclin dependent protein kinases in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16:2987–2997
   PubMedGoogle Scholar
• Dimri, G. P., Testori, A., Acosta, M., and Campisi, J.. 1996. Replicative senescence, aging and growth regulatory transcription factors. Biol. Signals 5:154–162
   PubMedGoogle Scholar
• Dyson, N.. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B.. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825
   PubMed Web of Science ®Google Scholar
• Field, S. J., Tsai, F. Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., and Greenberg, M. E.. 1996. E2F1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549–561
   PubMed Web of Science ®Google Scholar
• Freedman, D. A., Wu, L., and Levine, A. J.. 1999. Functions of the MDM2 oncoprotein. Mol. Life Sci. 55:96–107
   PubMed Web of Science ®Google Scholar
• Halbert, C. L., Demes, G. W., and Galloway, D. A.. 1992. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 66:2125–2134
   PubMed Web of Science ®Google Scholar
• Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., and Peters, G.. 1996. Regulation of p16/CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16:859–867
   PubMed Web of Science ®Google Scholar
• Harley, C. B.. 1991. Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 256:271–282
   PubMed Web of Science ®Google Scholar
• Hayflick, L.. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:614–636
   PubMed Web of Science ®Google Scholar
• Helin, K.. 1997. Regulation of cell proliferation by E2F transcription factors. Curr. Opin. Genet. Dev. 8:28–35
   Google Scholar
• Helin, K., Lees, J. A., Vidal, M., Dyson, N., Harlow, E., and Fattaey, A.. 1992. A cDNA encoding a pRB binding protein with properties of the transcription factor E2F. Cell 70:337–350
   PubMed Web of Science ®Google Scholar
• Hofferer, M., Wirbelauer, C., Humar, B., and Kerk, W.. 1999. Increased levels of E2F1 dependent DNA binding activity after UV- or gamma-irradiation. Nucleic Acids Res. 15:491–495
   Google Scholar
• Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A., and van Lohuizen, M.. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164–168
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., Schwarz, J. K., Cress, W. D., and Nevins, J. R.. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349–352
   PubMed Web of Science ®Google Scholar
• Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, R. A., Ashmun, G., Grosveld, G., and Sherr, C. J.. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659
   PubMed Web of Science ®Google Scholar
• Klingelhutz, A., Foster, S. A., and McDougall, J. K.. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79–83
   PubMed Web of Science ®Google Scholar
• Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., and Lowe, S. W.. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:3008–3019
   PubMed Web of Science ®Google Scholar
• McConnell, B. B., Starborg, M., Brookes, S., and Peters, G.. 1998. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8:351–354
   PubMed Web of Science ®Google Scholar
• Melillo, R. M., Helin, K., Lowy, D. R., and Schiller, J. T.. 1994. Positive and negative regulation of cell proliferation by E2F1: influence of protein level and human papilloma virus oncoproteins. Mol. Cell. Biol. 14:8241–8249
   PubMedGoogle Scholar
• Merlin, A. B., Gabai, V. L., Yaglom, J., Shifrin, V. I., and Sherman, M. Y.. 1998. Proteasome inhibitors activate stress kinases and induce Hsp72. J. Biol. Chem. 273:6373–6379
   PubMedGoogle Scholar
• Miller, A. D., and Rosman, G. J.. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980–988
   PubMed Web of Science ®Google Scholar
• Millis, A. J. T., Hoyle, M., McCue, H. M., and Martini, H.. 1992. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in diploid human fibroblasts. Exp. Cell Res. 201:373–379
   PubMed Web of Science ®Google Scholar
• Mishima, K., Handa, J. T., Aotaki-Keen, A., Lutty, G. A., Morse, L. S., and Hjelmeland, L. M.. 1999. Senescence-associated beta-galactosidase histochemistry for the primate eye. Invest. Ophthalmol. Vis. Sci. 40:1590–1593
   PubMedGoogle Scholar
• Morgenstern, J. P., and Land, H.. 1990. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587–3596
   PubMed Web of Science ®Google Scholar
• Neuman, E., Flemington, E. K., Sellers, W. R., Kaelin, W. G.Jr.. 1994. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14:6607–6615
   PubMed Web of Science ®Google Scholar
• Nevins, J. R.. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Nat. Genet. 9:585–593
   Google Scholar
• Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J.. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 21:90–98
   Google Scholar
• Ogryzko, V. V., Hirai, T. H., Russanova, V. R., Barbie, D. A., and Howard, B. H.. 1996. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16:5210–5218
   PubMed Web of Science ®Google Scholar
• Oswald, F., Lovec, H., Moroy, T., and Lipp, M.. 1994. E2F dependent regulation of human MYC: transactivation by cyclins D1 and A overrides tumor suppressor protein functions. Oncogene 9:2029–2036
   PubMedGoogle Scholar
• Pan, H., Yin, C., Dyson, N. J., Harlow, E., Yamasaki, L., and van Dyke, T.. 1998. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell 2:283–292
   PubMed Web of Science ®Google Scholar
• Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D.. 1993. Production of high titer helper free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396
   PubMed Web of Science ®Google Scholar
• Pendergrass, W. R., Lane, M. A., Bodkin, N. L., Hansen, B. C., Ingram, D. K., Roth, G. S., Yi, L., Bin, H., and Wolf, N. S.. 1999. Cellular proliferation potential during aging and caloric restriction in rhesus monkeys (Macaca mulatta). J. Cell. Physiol. 180:123–130
   PubMedGoogle Scholar
• Pierce, A. M., Gimenez-Conti, I. B., Schneider-Broussard, R., Martinez, L. A., Conti, C. J., and Johnson, D. G.. 1998. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. USA 95:8858–8863
   PubMed Web of Science ®Google Scholar
• Pomerantz, J., Schreiber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H. W., Cordon-Cardo, C., and DePinho, R. A.. 1998. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713–723
   PubMed Web of Science ®Google Scholar
• Qin, X. Q., Livingston, D. M., Kaelin, W. G., and Adams, P. D.. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918–10922
   PubMed Web of Science ®Google Scholar
• Rapp, L., and Chen, J. J.. 1998. The papillomavirus E6 proteins. Biochim. Biophys. Acta 1378:F1–F19
   PubMedGoogle Scholar
• Robertson, K. D., and Jones, P. A.. 1998. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol. 18:6457–6473
   PubMed Web of Science ®Google Scholar
• Robles, S. J., and Adami, G. R.. 1998. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16:1113–1123
   PubMed Web of Science ®Google Scholar
• Sager, R.. 1991. Senescence as a mode of tumor suppression. Environ. Health Perspect. 93:59–62
   PubMed Web of Science ®Google Scholar
• Saito, M., Helin, K., Valentine, M. B., Griffith, B. B., Willman, C. L., Harlow, E., and Look, A. T.. 1995. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. Genomics 25:130–138
   PubMedGoogle Scholar
• Saunders, N. A., Smith, R. J., and Jetten, A. M.. 1994. Regulation of proliferation-specific and differentiation-specific genes during senescence of human epidermal keratinocytes and mammary epithelial cells. Biochem. Biophys. Res. Commun. 197:46–54
   Google Scholar
• Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M.. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
   PubMed Web of Science ®Google Scholar
• Sedivy, J. M.. 1998. Can ends justify the means? Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. Proc. Natl. Acad. Sci. USA 95:9078–9081
   PubMedGoogle Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W.. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602
   PubMed Web of Science ®Google Scholar
• Shan, B., Durfee, T., and Lee, W. H.. 1996. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. USA 93:679–684
   PubMed Web of Science ®Google Scholar
• Shan, B., and Lee, W. H.. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14:8166–8173
   PubMedGoogle Scholar
• Sherr, C. J.. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984–2981
   PubMed Web of Science ®Google Scholar
• Smith, J. R., and Pereira-Smith, O. M.. 1996. Replicative senescence: implications for in vivo aging and tumor suppression. Science 273:63–67
   PubMed Web of Science ®Google Scholar
• Stein, G. H., Drullinger, L. F., Soulard, A., and Dulic, V.. 1999. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19:2109–2117
   PubMed Web of Science ®Google Scholar
• Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K. H., and Peters, G.. 1998. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:5001–5014
   PubMed Web of Science ®Google Scholar
• Tao, W., and Levine, A. J.. 1999. P19 (ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA 96:6937–6941
   PubMed Web of Science ®Google Scholar
• Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L., and Jacks, T.. 1998. Mutation of E2F-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2:293–304
   PubMed Web of Science ®Google Scholar
• West, M. D., Pereira-Smith, O. M., and Smith, J. R.. 1989. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp. Cell Res. 184:138–147
   PubMed Web of Science ®Google Scholar
• Wright, W. E., and Shay, J. W.. 1996. Mechanism of escaping senescence in human diploid cells Modern cell biology series. Cellular aging and cell death. Holbrook, N. J., Martin, G. R., and Lockshin, R. A. 153–167 Wiley & Sons, Inc., New York, N.Y
   Google Scholar
• Wu, X., and Levine, A. J.. 1994. P53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3601–3606
   Google Scholar
• Yamasaki, L., Bronson, R., Williams, B. O., Dyson, N. J., Harlow, E., and Jacks, T.. 1998. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice. Nat. Genet. 18:360–364
   PubMed Web of Science ®Google Scholar
• Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N. J.. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537–548
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Xiong, Y., and Yarbrough, W. G.. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways. Cell 92:725–734
   PubMed Web of Science ®Google Scholar
• Zhu, J., Woods, D., McMahon, M., and Bishop, J. M.. 1998. Senescence of human fibroblasts induced by oncogenic raf. Genes Dev. 12:2997–3007
   PubMed Web of Science ®Google Scholar
• Zindy, F., Eischen, C. M., Randle, D., Kamijo, T., Cleveland, J. L., Sherr, C. J., and Roussel, M. F.. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424–2434
   PubMed Web of Science ®Google Scholar